ACSM2B

ACSM2B
Identifiers
Gene ontology
Molecular function	nucleotide binding; ligase activity; catalytic activity; ATP binding; metal ion binding; butyrate-CoA ligase activity; CoA-ligase activity; fatty-acyl-CoA synthase activity; fatty acid ligase activity; molecular function;
Cellular component	mitochondrion; mitochondrial matrix;
Biological process	xenobiotic metabolic process; metabolism; fatty acid metabolic process; lipid metabolism; fatty acid biosynthetic process; acyl-CoA metabolic process;
	Sources:Amigo / QuickGO

Ensembl


ENSG00000066813


n/a

UniProt


Q68CK6


n/a

RefSeq (mRNA)


NM_001105069 NM_182617


n/a

RefSeq (protein)


NP_001098539 NP_872423


n/a

Location (UCSC)

Chr 16: 20.54 – 20.58 Mb

n/a

PubMed search

^[2]

n/a

Wikidata

View/Edit Human

Acyl-coenzyme A synthetase ACSM2B, mitochondrial is an enzyme that in humans is encoded by the ACSM2B gene.^[3]^[4]

References

^ ^a ^b ^c GRCh38: Ensembl release 89: ENSG00000066813 – Ensembl, May 2017
^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
S2CID 13396633
.

^ "Entrez Gene: ACSM2 acyl-CoA synthetase medium-chain family member 2".

External links

Human ACSM2B genome location and ACSM2B gene details page in the UCSC Genome Browser.

Further reading

Lindner I, Rubin D, Helwig U, et al. (2006). "The L513S polymorphism in medium-chain acyl-CoA synthetase 2 (MACS2) is associated with risk factors of the metabolic syndrome in a Caucasian study population". Mol Nutr Food Res. 50 (3): 270–4.
PMID 16521160
.

Yamada S, Ohira M, Horie H, et al. (2004). "Expression profiling and differential screening between hepatoblastomas and the corresponding normal livers: identification of high expression of the PLK1 oncogene as a poor-prognostic indicator of hepatoblastomas". Oncogene. 23 (35): 5901–11.
PMID 15221005
.

Vessey DA, Kelley M, Warren RS (2004). "Characterization of triacsin C inhibition of short-, medium-, and long-chain fatty acid: CoA ligases of human liver". J. Biochem. Mol. Toxicol. 18 (2): 100–6.
S2CID 8154380
.

Vessey DA, Kelley M (2001). "Characterization of the reaction mechanism for the XL-I form of bovine liver xenobiotic/medium-chain fatty acid:CoA ligase". Biochem. J. 357 (Pt 1): 283–8.
PMID 11415461
.

Vessey DA, Kelley M, Warren RS (1999). "Characterization of the CoA ligases of human liver mitochondria catalyzing the activation of short- and medium-chain fatty acids and xenobiotic carboxylic acids". Biochim. Biophys. Acta. 1428 (2–3): 455–62.
PMID 10434065
.

Vessey DA, Hu J (1997). "Isolation from bovine liver mitochondria and characterization of three distinct carboxylic acid: CoA ligases with activity toward xenobiotics". J. Biochem. Toxicol. 10 (6): 329–37.
PMID 8934636
.

Vessey DA, Hu J, Kelley M (1997). "Interaction of salicylate and ibuprofen with the carboxylic acid: CoA ligases from bovine liver mitochondria". J. Biochem. Toxicol. 11 (2): 73–8.
PMID 8884467
.

This enzyme-related article is a stub. You can help Wikipedia by expanding it.
v
t
e

Retrieved from "https://en.wikipedia.org/w/index.php?title=ACSM2B&oldid=1166578688"

[refGRCh38Ensembl-1] GRCh38: Ensembl release 89: ENSG00000066813 – Ensembl, May 2017

[2] "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.

[pmid12616642-3] S2CID 13396633
.

[entrez-4] "Entrez Gene: ACSM2 acyl-CoA synthetase medium-chain family member 2".

[2]

[3]

[4]